News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,758 Results
Type
Article (40005)
Company Profile (250)
Press Release (664502)
Multimedia
Podcasts (58)
Webinars (14)
Section
Business (204274)
Career Advice (2011)
Deals (35453)
Drug Delivery (95)
Drug Development (81137)
Employer Resources (172)
FDA (16249)
Job Trends (14886)
News (345495)
Policy (32605)
Tag
Academia (2556)
Accelerated approval (9)
Adcomms (22)
Allergies (95)
Alliances (49569)
ALS (108)
Alzheimer's disease (1438)
Antibody-drug conjugate (ADC) (151)
Approvals (16244)
Artificial intelligence (307)
Autoimmune disease (28)
Automation (18)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (121)
Biotechnology (175)
Bladder cancer (93)
Brain cancer (33)
Breast cancer (364)
Cancer (2852)
Cardiovascular disease (211)
Career advice (1681)
Career pathing (30)
CAR-T (185)
CDC (30)
Cell therapy (496)
Cervical cancer (22)
Clinical research (66832)
Collaboration (1011)
Company closure (3)
Compensation (686)
Complete response letters (22)
COVID-19 (2624)
CRISPR (56)
C-suite (321)
Cystic fibrosis (111)
Data (2982)
Decentralized trials (2)
Denatured (20)
Depression (60)
Diabetes (346)
Diagnostics (6423)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (135)
Drug pricing (121)
Drug shortages (28)
Duchenne muscular dystrophy (124)
Earnings (87437)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (113724)
Executive appointments (845)
FDA (17888)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (928)
Gene editing (129)
Generative AI (22)
Gene therapy (372)
GLP-1 (780)
Government (4499)
Grass and pollen (4)
Guidances (181)
Healthcare (18839)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (146)
Immuno-oncology (8)
Indications (39)
Infectious disease (2795)
Inflammatory bowel disease (147)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (119)
Interviews (312)
IPO (16591)
IRA (44)
Job creations (3636)
Job search strategy (1424)
Kidney cancer (13)
Labor market (52)
Layoffs (491)
Leadership (18)
Legal (7929)
Liver cancer (79)
Lung cancer (399)
Lymphoma (208)
Machine learning (11)
Management (58)
Manufacturing (381)
MASH (90)
Medical device (13456)
Medtech (13461)
Mergers & acquisitions (19575)
Metabolic disorders (845)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (113)
Neuropsychiatric disorders (31)
Neuroscience (2111)
NextGen: Class of 2025 (6517)
Non-profit (4488)
Now hiring (47)
Obesity (425)
Opinion (217)
Ovarian cancer (100)
Pain (104)
Pancreatic cancer (120)
Parkinson's disease (186)
Partnered (22)
Patents (295)
Patient recruitment (160)
Peanut (50)
People (57676)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20827)
Phase II (29439)
Phase III (21907)
Pipeline (1620)
Policy (198)
Postmarket research (2563)
Preclinical (8866)
Press Release (64)
Prostate cancer (139)
Psychedelics (36)
Radiopharmaceuticals (253)
Rare diseases (455)
Real estate (5917)
Recruiting (66)
Regulatory (22621)
Reports (50)
Research institute (2325)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (156)
Series B (108)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3587)
State (2)
Stomach cancer (14)
Supply chain (75)
Tariffs (57)
The Weekly (36)
Vaccines (778)
Venture capital (53)
Weight loss (255)
Women's health (46)
Worklife (16)
Date
Today (43)
Last 7 days (385)
Last 30 days (1806)
Last 365 days (31215)
2025 (16654)
2024 (35219)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (720)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38201)
Australia (6232)
California (7409)
Canada (2351)
China (669)
Colorado (320)
Connecticut (316)
Delaware (192)
Europe (82089)
Florida (1115)
Georgia (247)
Hawaii (1)
Idaho (59)
Illinois (636)
India (26)
Indiana (360)
Iowa (16)
Japan (227)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1019)
Massachusetts (5510)
Michigan (245)
Minnesota (448)
Mississippi (3)
Missouri (89)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (66)
New Jersey (2068)
New Mexico (28)
New York (2082)
North Carolina (1077)
North Dakota (8)
Northern California (3261)
Ohio (235)
Oklahoma (16)
Oregon (34)
Pennsylvania (1609)
Puerto Rico (17)
Rhode Island (36)
South America (1098)
South Carolina (34)
South Dakota (1)
Southern California (2768)
Tennessee (125)
Texas (1114)
United States (27470)
Utah (219)
Virginia (183)
Washington D.C. (72)
Washington State (629)
West Virginia (4)
Wisconsin (65)
704,758 Results for "surmodics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.
Surmodics, Inc. announced it has been awarded a group purchasing agreement for thrombectomy products with Premier, Inc. Effective June 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Surmodics Pounce™ and Pounce™ Venous Thrombectomy Systems.
June 10, 2024
·
4 min read
Press Releases
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
April 28, 2025
·
1 min read
Press Releases
Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon
April 23, 2025
·
7 min read
Press Releases
Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance
April 30, 2025
·
20 min read
BioMidwest
Surmodics to Participate in Upcoming Investor Conferences in March and April
Surmodics, Inc. today announced that management will participate in the following upcoming investor conferences.
February 27, 2024
·
1 min read
Press Releases
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results
January 30, 2025
·
19 min read
Business
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Surmodics, Inc today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, May 1.
April 19, 2024
·
2 min read
Deals
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
Surmodics, Inc. today announced that it has entered into a definitive agreement to be acquired by GTCR, a leading private equity firm with a long track record of investment expertise across healthcare and healthcare technology.
May 29, 2024
·
9 min read
BioMidwest
Surmodics to Host Virtual Annual Meeting of Shareholders - January 16, 2024
Surmodics, Inc. will hold its Annual Meeting of Shareholders on Thursday, February 8, at 4 p.m. CT (5 p.m. ET), as a virtual meeting.
January 16, 2024
·
1 min read
Business
Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
Surmodics, Inc. today announced that first quarter of fiscal year 2024 financial results will be released before the market opens on Thursday, February 1.
January 16, 2024
·
2 min read
1 of 70,476
Next
